A Curve‐Free Method for Phase I Clinical Trials (Q4667490)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 2159529
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A Curve‐Free Method for Phase I Clinical Trials |
scientific article; zbMATH DE number 2159529 |
Statements
A Curve‐Free Method for Phase I Clinical Trials (English)
0 references
20 April 2005
0 references
continual reassessment method
0 references
dose-finding studies
0 references
maximum tolerated dose
0 references
neutral to the right process
0 references
phase I clinical trial
0 references
product-of-beta priors
0 references
toxicity
0 references
0 references
0.8290314078330994
0 references
0.8236656188964844
0 references
0.8113520741462708
0 references
0.802959144115448
0 references
0.8022723197937012
0 references
